Resveratrol and Endothelial Nitric Oxide
AbstractNitric oxide (NO) derived from the endothelial NO synthase (eNOS) has antihypertensive, antithrombotic, anti-atherosclerotic and antiobesogenic properties. Resveratrol is a polyphenol phytoalexin with multiple cardiovascular and metabolic effects. Part of the beneficial effects of resveratrol are mediated by eNOS. Resveratrol stimulates NO production from eNOS by a number of mechanisms, including upregulation of eNOS expression, stimulation of eNOS enzymatic activity and reversal of eNOS uncoupling. In addition, by reducing oxidative stress, resveratrol prevents oxidative NO inactivation by superoxide thereby enhancing NO bioavailability. Molecular pathways underlying these effects of resveratrol involve SIRT1, AMPK, Nrf2 and estrogen receptors. View Full-Text
Share & Cite This Article
Xia, N.; Förstermann, U.; Li, H. Resveratrol and Endothelial Nitric Oxide. Molecules 2014, 19, 16102-16121.
Xia N, Förstermann U, Li H. Resveratrol and Endothelial Nitric Oxide. Molecules. 2014; 19(10):16102-16121.Chicago/Turabian Style
Xia, Ning; Förstermann, Ulrich; Li, Huige. 2014. "Resveratrol and Endothelial Nitric Oxide." Molecules 19, no. 10: 16102-16121.